Paper10567494
BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy.
Strik H and 7 others. J Neurol Neurosurg Psychiatry, 1999. Cited by 111 papers, by iCite.
Cite this record
ConductScience Library. BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. Papers, record 10567494. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10567494
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Central Nervous System Neoplasms | Major topic |
| Gene Expression | Major topic |
| Glioblastoma | Major topic |
| Proto-Oncogene Proteins c-bcl-2 | Major topic |
| Up-Regulation | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Apoptosis | |
| Combined Modality Therapy | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Recurrence, Local |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 355604 | Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. | J Neurosurg | 1978 | https://conductscience.org/library/papers/355604 | PubMed |
| 2 | 9804374 | Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. | Brain Pathol | 1998 | https://conductscience.org/library/papers/9804374 | PubMed |
| 3 | 8358789 | bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. | Cell | 1993 | https://conductscience.org/library/papers/8358789 | PubMed |
| 4 | 8358790 | Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. | Cell | 1993 | https://conductscience.org/library/papers/8358790 | PubMed |
| 5 | 7867012 | Human gliomas with wild-type p53 express bcl-2. | Cancer Res | 1995 | https://conductscience.org/library/papers/7867012 | PubMed |
| 6 | 7879598 | bcl-2 protein expression in tumors of the central nervous system. | Acta Neuropathol | 1994 | https://conductscience.org/library/papers/7879598 | PubMed |
| 7 | 7539458 | Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. | J Clin Invest | 1995 | https://conductscience.org/library/papers/7539458 | PubMed |
| 8 | 7494604 | Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. | Neuropathol Appl Neurobiol | 1995 | https://conductscience.org/library/papers/7494604 | PubMed |
| 9 | 7490615 | Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy. | J Neurosurg | 1995 | https://conductscience.org/library/papers/7490615 | PubMed |
| 10 | 8538748 | Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. | Nature | 1996 | https://conductscience.org/library/papers/8538748 | PubMed |
| 11 | 8616866 | Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. | Cancer Res | 1996 | https://conductscience.org/library/papers/8616866 | PubMed |
| 12 | 8699231 | Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study. | J Neurooncol | 1996 | https://conductscience.org/library/papers/8699231 | PubMed |
| 13 | 8690508 | Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. | Int J Cancer | 1996 | https://conductscience.org/library/papers/8690508 | PubMed |
| 14 | 8781438 | Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide. | Blood | 1996 | https://conductscience.org/library/papers/8781438 | PubMed |
| 15 | 8782646 | Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells. | Int J Cancer | 1996 | https://conductscience.org/library/papers/8782646 | PubMed |
| 16 | 8798452 | Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8798452 | PubMed |
| 17 | 9042164 | Role of gemistocytes in astrocytoma progression. | Lab Invest | 1997 | https://conductscience.org/library/papers/9042164 | PubMed |
| 18 | 9060818 | Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin. | Am J Pathol | 1997 | https://conductscience.org/library/papers/9060818 | PubMed |
| 19 | 9209397 | Bcl-2 and Bcl-xL block apoptosis as well as necrosis: possible involvement of common mediators in apoptotic and necrotic signal transduction pathways. | Leukemia | 1997 | https://conductscience.org/library/papers/9209397 | PubMed |
| 20 | 9266097 | Changes of biological features in breast cancer cells determined by primary chemotherapy. | Breast Cancer Res Treat | 1997 | https://conductscience.org/library/papers/9266097 | PubMed |
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42818713 | High-throughput spheroid profiling reveals BMP-driven rewiring of glioma cell death responses. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818713 | PubMed |
| 41653375 | Centratherin Exhibits Antitumor Activity Against Glioblastoma Cells. | Neurochem Res | 2026 | https://conductscience.org/library/papers/41653375 | PubMed |
| 39503973 | Cell death in glioblastoma and the central nervous system. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/39503973 | PubMed |
| 37651309 | Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High-Grade Gliomas. | J Proteome Res | 2023 | https://conductscience.org/library/papers/37651309 | PubMed |
| 36660193 | Antineoplastic multi-drug chemotherapy to sensitize tumors triggers multi-drug resistance and inhibits efficiency of maintenance treatment inglioblastoma cells. | EXCLI J | 2023 | https://conductscience.org/library/papers/36660193 | PubMed |
| 36273072 | Noxa and Mcl-1 expression influence the sensitivity to BH3-mimetics that target Bcl-xL in patient-derived glioma stem cells. | Sci Rep | 2022 | https://conductscience.org/library/papers/36273072 | PubMed |
| 35582046 | Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions. | Cancer Drug Resist | 2020 | https://conductscience.org/library/papers/35582046 | PubMed |
| 35159079 | Gas Plasma Exposure of Glioblastoma Is Cytotoxic and Immunomodulatory in Patient-Derived GBM Tissue. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35159079 | PubMed |
| 34485282 | Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34485282 | PubMed |
| 34118966 | Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34118966 | PubMed |
| 33919846 | Overcoming TRAIL Resistance for Glioblastoma Treatment. | Biomolecules | 2021 | https://conductscience.org/library/papers/33919846 | PubMed |
| 33665742 | The Role of the Ubiquitin Proteasome System in Glioma: Analysis Emphasizing the Main Molecular Players and Therapeutic Strategies Identified in Glioblastoma Multiforme. | Mol Neurobiol | 2021 | https://conductscience.org/library/papers/33665742 | PubMed |
| 33023187 | Profiling Anti-Apoptotic BCL-xL Protein Expression in Glioblastoma Tumorspheres. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33023187 | PubMed |
| 32752193 | Epigenetic Targeting of Mcl-1 Is Synthetically Lethal with Bcl-xL/Bcl-2 Inhibition in Model Systems of Glioblastoma. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32752193 | PubMed |
| 31842413 | Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31842413 | PubMed |
| 31825969 | Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level. | PLoS Comput Biol | 2019 | https://conductscience.org/library/papers/31825969 | PubMed |
| 31551765 | α-Hispanolol Induces Apoptosis and Suppresses Migration and Invasion of Glioblastoma Cells Likely via Downregulation of MMP-2/9 Expression and p38MAPK Attenuation. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31551765 | PubMed |
| 31493044 | Bcl-2 Overexpression Induces Neurite Outgrowth via the Bmp4/Tbx3/NeuroD1 Cascade in H19-7 Cells. | Cell Mol Neurobiol | 2020 | https://conductscience.org/library/papers/31493044 | PubMed |
| 30486451 | Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30486451 | PubMed |
| 30446901 | Lower expression of Bax predicts poor clinical outcome in patients with glioma after curative resection and radiotherapy/chemotherapy. | J Neurooncol | 2019 | https://conductscience.org/library/papers/30446901 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| BCL2L1 | 598 | PubTator's text mining | https://conductscience.org/library/genes/598 | NCBI Gene |
| MCL1 | 4170 | PubTator's text mining | https://conductscience.org/library/genes/4170 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10567494
GET https://conductscience.org/api/papers/v1/10567494/references?page=2